Kacey J. Rosenthal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kacey J. Rosenthal has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- John D. Scott
Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington
2 shared publications Carmen W. Dessauer
Department of Integrative Biology and Pharmacology, McGovern Medical School at University of Texas Health Science Center Houston, Houston, Texas, USA
1 shared publicationCassandra J. Wong
Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Ontario, USA
1 shared publicationClaudia Moreno
Howard Hughes Medical Institute, Department of Neurobiology and Biophysics, University of Washington School of Medicine, Seattle, Washington, USA
1 shared publicationJames E. Bruce
Department of Genome Sciences, University of Washington School of Medicine, Seattle, Washington, USA
1 shared publication- Jerome I. Falcone
Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington, USA
1 shared publication
Latest Publications
- Open Access
- 29 May 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (7) , 110317
Long AKAP18 isoforms anchor ubiquitin specific proteinases and coordinate calcium reuptake at the sarcoplasmic reticulum
- 29 May 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (7) , 110317
Open AccessLong AKAP18 isoforms anchor ubiquitin specific proteinases and coordinate calcium reuptake at the sarcoplasmic reticulum
- 14 November 2024
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 481 (22) , 1659-1677
Protein kinase A and local signaling in cancer
Protein kinase A (PKA) is a basophilic kinase implicated in the modulation of many cell-signaling and physiological processes. PKA also contributes to cancer-relevant events such as growth factor action, cell cycle control, cell migration and tumor metabolism. Germline and somatic mutations in PKA, gene amplifications, and chromosome rearrangements that encode kinase fusions, are linked to a growing number of malignant neoplasms. Mislocalization of PKA by exclusion from A-Kinase Anchoring Protein (AKAP) signaling islands further underlies cancer progression. This article highlights the influence of AKAP signaling and local kinase action in selected hallmarks of cancer. We also feature the utility of kinase inhibitor drugs as frontline and future anti-cancer therapies.
- 14 November 2024
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 481 (22) , 1659-1677
Protein kinase A and local signaling in cancer
Protein kinase A (PKA) is a basophilic kinase implicated in the modulation of many cell-signaling and physiological processes. PKA also contributes to cancer-relevant events such as growth factor action, cell cycle control, cell migration and tumor metabolism. Germline and somatic mutations in PKA, gene amplifications, and chromosome rearrangements that encode kinase fusions, are linked to a growing number of malignant neoplasms. Mislocalization of PKA by exclusion from A-Kinase Anchoring Protein (AKAP) signaling islands further underlies cancer progression. This article highlights the influence of AKAP signaling and local kinase action in selected hallmarks of cancer. We also feature the utility of kinase inhibitor drugs as frontline and future anti-cancer therapies.